Drug delivery to the ocular posterior segment using lipid emulsion via eye drop administration: Effect of emulsion formulations and surface modification

International Journal of Pharmaceutics

Volumn 453, Issue 2, 2013, Pages 329-335

  Ying, Lin ^a   Tahara, Kohei ^a   Takeuchi, Hirofumi ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Lipid emulsion; Posterior segment; Retina; Surface modification; Topical administration

Indexed keywords

CASTOR OIL; COUMARIN 6; COUMARIN DERIVATIVE; DRUG CARRIER; EYE DROPS; LIPID EMULSION; LIPOSOME; PHOSPHOLIPID; POLOXAMER; POLYMER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; FLUORESCENCE MICROSCOPY; HYPERBARISM; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; POSTERIOR EYE SEGMENT; PRIORITY JOURNAL; SURFACE CHARGE; SURFACE PROPERTY; ZETA POTENTIAL;

EID: 84884161844     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.06.024     Document Type: Article

References (29)

1. Anumolu, S.S., Singh, Y., Gao, D., Stein, S., Sinko, P.J., 2009. Design and evaluation of novel fast forming pilocarpine-loaded ocular hydrogels for sustained pharmacological response. J. Controlled Release 137, 152-159.
2. Bach, A.C., Babayan, V.K., 1982. Medium-chain triglycerides: an update. Am. J. Clin. Nutr. 36, 950-962. (Pubitemid 13214366)
3. Beer, P.M., Bakri, S.J., Singh, R.J., Liu, W., Peters 3rd., G.B., Miller, M., 2003. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology 110, 681-686. (Pubitemid 36520063)
4. Calvo, P., Vil-Jato, J.L., Alonso, M.J., 1996. Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules, and nanoemulsions, as ocular drug carriers. J. Pharm. Sci. 85, 530-536. (Pubitemid 26153217)
5. Calvo, P., Vila-Jato, J.L., Alonso, M.J., 1997. Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers. Int. J. Pharm. 153, 41-50. (Pubitemid 27283332)
6. Dumortier, G., Grossiord, J.L., Agnely, F., Chaumeil, J.C., 2006. A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm. Res. 23, 2709-2728. (Pubitemid 44885361)
7. El-Shabouri, M.E., 2002. Positively charged nanoparticles for improving the oral bioavailability of cyclosporine-A. Int. J. Pharm. 249, 101-108.
8. Enríquez de Salamanca, A., Diebold, Y., Calonge, M., García-Vazquez, C., Callejo, S., Vila, A., Alonso, M.J., 2006. Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance. Invest. Ophthalmol. Vis. Sci. 47, 1416-1425. (Pubitemid 46780748)
9. Fujisawa, T., Miyai, H., Hironaka, K., Tsukamoto, T., Tahara, K., Tozuka, Y., Ito, M., Takeuchi, H., 2012. Liposomal diclofenac eye drop formulations targeting the retina: formulation stability improvement using surface modification of liposomes. Int. J. Pharm. 436, 564-567.
10. Hironaka, K., Inokuchi, Y., Tozuka, Y., Shimazawa, M., Hara, H., Takeuchi, H., 2009. Design and evaluation of a liposomal delivery system targeting the posterior segment of the eye. J. Control. Release 136, 247-253.
11. Hughes, P.M., Olejnik, O., Chang-Lin, J.E., Wilson, C.G., 2005. Topical and systemic drug delivery to the posterior segments. Adv. Drug Deliv. Rev. 57, 2010-2032. (Pubitemid 41740793)
12. Inokuchi, Y., Hironaka, K., Fujisawa, T., Tozuka, Y., Tsuruma, K., Shimazawa, M., Takeuchi, H., Hara, H., 2010. Physicochemical properties affecting retinal drug/coumarin-6 delivery from nanocarrier systems via eyedrop administration. Invest. Ophthalmol. Vis. Sci. 51, 3162-3170.
13. Jager, R.D., Aiello, L.P., Patel, S.C., Cunningham, E.T., 2004. Risks of intravitreous injection: a comprehensive review. Retina 24, 676-698. (Pubitemid 39391758)
14. Jamal, K.N., Callanan, D.G., 2009. The role of difluprednate ophthalmic emulsion in clinical practice. Clin. Ophthalmol. 3, 381-390.
15. Jiao, J., 2008. Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery. Adv. Drug Deliv. Rev. 60, 1663-1673.
16. Lallemand, F., Daull, P., Benita, S., Buggage, R., Garrigue, J.S., 2012. Successfully improving ocular drug delivery using the cationic nanoemulsion. Novasorb. J. Drug Deliv., http://dx.doi.org/10.1155/2012/604204.
17. Li, N., Zhuang, C.Y., Wang, M., Sui, C.G., Pan, W.S., 2012. Low molecular weight chitosan-coated liposomes for ocular drug delivery: in vitro and in vivo studies. Drug Deliv. 19, 28-35.
18. Pepić, I., Hafner, A., Lovrić, J., Pirkić, B., Filipović-Grčić, J., 2010. A nonionic surfactant/chitosan micelle system in an innovative eye drop formulation. J. Pharm. Sci. 99, 4317-4325.
19. Sall, K.N., Cohen, S.M., Christensen, M.T., Stein, J.M., 2006. An evaluation of the efficacy of a cyclosporine-based dry eye therapy when used with marketed artificial tears as supportive therapy in dry eye. Eye Contact Lens 32, 21-26. (Pubitemid 43189090)
20. Samad, A., Sultana, Y., Aquil, M., 2007. Liposomal drug delivery systems: an update review. Curr. Drug Deliv. 4, 297-305. (Pubitemid 47554274)
21. Sasaki, H., Karasawa, K., Hironaka, K., Tahara, K., Tozuka, Y., Takeuchi, H., 2013. Retinal drug delivery using eye drop preparations of poly-L-lysine-modified liposome. Eur. J. Pharm. Biopharm. 83, 364-369.
22. Shimazawa, M., Inokuchi, Y., Ito, Y., Murata, H., Aihara, M., Miura, M., Araie, M., Hara, H., 2007. Involvement of ER stress in retinal cell death. Mol. Vis. 13, 578-587. (Pubitemid 46561917)
23. Shi, S., Chen, H., Cui, Y., Tang, X., 2009. Formulation, stability and degradation kinetics of intravenous cinnarizine lipid emulsion. Int. J. Pharm. 373, 147-155.
24. Su, M., Zhao, M.M., Luo, Y.F., Lin, X., Xu, L.S., He, H.B., Xu, H., Tang, X., 2011. Evaluation of the efficacy, toxicity and safety of vinorelbine incorporated in a lipid emulsion. Int. J. Pharm. 411, 188-196.
25. Tahara, K., Kato, Y., Yamamoto, H., Kreuter, J., Kawashima, Y., 2011. Intracellular drug delivery using polysorbate 80-modified poly(D, L-lactide-co-glycolide) nanospheres toglioblastoma cells. J. Microencapsulation 28, 29-36.
26. Tamilvanan, S., 2004. Oil-in-water lipid emulsions: implications for parenteral and ocular delivering systems. Prog. Lipid Res. 43, 489-533. (Pubitemid 39441344)
27. Tian, B.C., Luo, Q.H., Song, S.S., Liu, D.D., Pan, H., Zhang, W.J., He, L., Ma, S.L., Yang, X.G., Pan, W.S., 2011. Novel surface-modified nanostructured lipid carriers with partially deacetylated water-soluble chitosan for efficient ocular delivery. J. Pharm. Sci. 101, 1040-1049.
28. Yamaguchi, M., Ueda, K., Isowak, A., Ohtori, A., Takeuchi, H., Ohguro, N., Tojo, K., 2009. Mucoadhesive properties of chitosan-coated ophthalmic lipid emulsion containing indomethacin in tear fluid. Biol. Pharm. Bull. 32, 1266-1271.
29. Zhao, M.M., Su, M., Lin, X., Luo, Y.F., He, H.B., Cai, C.F., Tang, X., 2010. Evaluation of docetaxel-loaded intravenous lipid emulsion: pharmacokinetics, tissue distribution, antitumor activity, safety and toxicity. Pharm. Res. 27, 1687-1702.